Skip to main content

IDWeek 2022 Main banner

Tweets by IDWeek 2022

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Back

Susanne Paukner, PhD

Vice President Microbiology
Nabriva Therapeutics, Austria

Disclosure(s): Nabriva Therapeutics: Employee, Inventor, Stocks/Bonds

Poster(s):

1689 - In Vitro Activity of Lefamulin Against Bacterial Pathogens Collected From Pneumonia Patients in United States and Latin America Medical Centers in 2020-2021
Saturday, October 22, 2022
12:15 PM – 1:30 PM US ET
2189 - Anti-inflammatory Activity of Lefamulin in a Mouse Model of Influenza Virus H1N1 Infection
Saturday, October 22, 2022
12:15 PM – 1:30 PM US ET